All stock reports

MEDPLUS evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-22T14:02:08.182121+00:00

Metrics

latest_annual_period
2026-03-31
revenue
68924660000.0
net_income
2196490000.0
operating_cash_flow
5269940000.0
free_cash_flow
4039640000.0
total_assets
39325260000.0
total_liabilities
19578720000.0
total_equity
19753590000.0
cash
4621620000.0
total_debt
14243830000.0
revenue_growth
0.12327354408444657
earnings_growth
0.4611899788454119
net_margin
0.031867984550087006
roe
0.11119447148594255
debt_to_equity
0.7210755108311957
cash_conversion
2.3992551753024145
free_cash_flow_margin
0.05860950202728603
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-efa2602e464a9e5e76d46896bb4b0783d00c8d8b771c8202cfe1fe30a60fc9ae
Policy
stock-decisions-v1
Evidence bundle hash
d3c3d8512f2a0b8e9c4325959009438eb897264023a7b2d7924392a92d69c2df
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 94444c58db1d7ba53b75310dcd8ef08c9b4f85edcdbf7c6c454c84265d9954d2
  • daily-price: de2ba9e29948bf66f8072a3611eb9d690b267f264e0f56545c991cec67f09f70
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.12327354408444657. The cached financial metric net margin is 0.031867984550087006. The cached financial metric roe is 0.11119447148594255. The cached financial metric debt to equity is 0.7210755108311957. The cached financial metric cash conversion is 2.3992551753024145.

Risks

The trailing 60-session price return was -19.84%. The trailing 250-session price return was -18.13%. The closing price was -31.41% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Price source verification: REPAIRED. Average cached traded value over twenty sessions was INR 64,802,076.

Cached observations and evidence limits